Search Results - "Guidez, F."

Diverse roles of YTHDC1 in chromatin and blood cancers.

Authors: Pernon B Benchikh Y Fournier C et al.

Source: Frontiers in genetics [Front Genet] 2026 May 08; Vol. 17, pp. 1773468. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE

Critical Role of Molecular-Based Stratification in Low-Risk Myelodysplastic Syndrome with Direct Progression to Acute Myeloid Leukemia: A Case Report.

Authors: Mihai, Stejara Nicoleta Dragu, Denisa Mambet, Cristina et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 10, p4557. 11p.

The SETD2 L1609P mutation found in leukemia disrupts methyltransferase activity and reduces histone H3K36 trimethylation.

Authors: Michail C Berthelet J Mechaly AE et al.

Source: The Journal of biological chemistry [J Biol Chem] 2026 Mar; Vol. 302 (3), pp. 111259. Date of Electronic Publication: 2026 Feb 05.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE

Clinical Phenotype, Molecular Architecture, and Survival Follow-Up in NRAS- and KRAS-Mutated Juvenile Myelomonocytic Leukemia.

Authors: Zhang, Bang Liu, Chenmeng Li, Xiaolan et al.

Source: Cancers. Jul2026, Vol. 18 Issue 14, p2236. 21p.

Angptl5 restricts primitive hematopoiesis by promoting retinoic acid signaling in zebrafish.

Authors: Mo, Jing Zhuo, Ding-Hao Gao, Min et al.

Source: PLoS Biology. 6/25/2026, Vol. 24 Issue 6, p1-25. 25p.

Volume 20 Author Index.

Source: Oncogene. 12/20/2001 Review, Vol. 20 Issue 58, p8359. 19p.

Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets.

Authors: Zhou H Xiang W Zhou G et al.

Source: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Dec 07; Vol. 42 (1), pp. 23. Date of Electronic Publication: 2024 Dec 07.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE

Inactivation of PRMT5 by PARP Inhibitors Confers High Susceptibility in MTAP-Deficient Cancers.

Authors: Liu, Qi Sheng, Yuling Lin, Folan et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1335. 15p.

A porcine model of Fanconi anemia.

Authors: Hergert, Brandon Whitworth, Kristin M. Goldman, Devorah C. et al.

Source: PLoS ONE. 10/31/2025, Vol. 20 Issue 10, p1-15. 15p.

Rethinking medical education through systems biology to address complexity.

Authors: David, Laurent Gourraud, Pierre-Antoine Lamirault, Guillaume et al.

Source: NPJ Systems Biology & Applications. 1/6/2026, Vol. 12 Issue 1, p1-6. 6p.

Volume 19 author index.

Source: Oncogene. 12/27/2000 Review, Vol. 19 Issue 56, p6693. 8p.

Epigenetic Regulation in Acute Myeloid Leukemia: Molecular Mechanisms and Clinical Implications.

Authors: Xu, Jingru Lacaud, Georges

Source: Cancers. Jul2026, Vol. 18 Issue 14, p2203. 21p.

LINE-1 Retrotransposons and Amyotrophic Lateral Sclerosis.

Authors: Korošec, Tinkara Rogelj, Boris Župunski, Vera

Source: International Journal of Molecular Sciences. Jul2026, Vol. 27 Issue 14, p6244. 23p.

Cetyl All- Trans -Retinoate as a Lipidic ATRA Prodrug with Enhanced Anticancer and Chemosensitizing Activity.

Authors: Moroz, Paweł Muciek, Klaudia Świtalska, Marta et al.

Source: International Journal of Molecular Sciences. Jul2026, Vol. 27 Issue 13, p5982. 22p.

Myeloid Malignancies Beyond the Cell: Targeting the Tumour Microenvironment with Next-Generation Immunotherapies.

Authors: Amirian, Niloofar Squires, Anya Azanabor, Lauretta et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1808. 29p.

Therapeutic potential of PRMT1 as a critical survival dependency target in multiple myeloma.

Authors: Hussain, Tabish Awasthi, Sharad Shahid, Farid et al.

Source: BMC Cancer. 11/4/2025, Vol. 25 Issue 1, p1-15. 15p.

Successfully treatment of PLZF-RARα positive acute promyelocytic leukemia by Venetoclax combining with decitabine: a case report and literature review.

Authors: Zhou, Ziwei Chen, Erling Jiang, Jiqian et al.

Source: Hematology. Dec2024, Vol. 29 Issue 1, p1-4. 4p.

Molecular Advances in Juvenile Myelomonocytic Leukemia and Associated RASopathy.

Authors: Monika, Fnu Abu Mehsen, Sara Zhang, Ling

Source: Cancers. May2026, Vol. 18 Issue 10, p1655. 30p.

CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.

Authors: Lim, Kelly Kan, Winnie L. Nair, Pramod C. et al.

Source: PLoS ONE. 9/19/2024, Vol. 19 Issue 9, p1-19. 19p.

ETS Transcription Factors in Immune Cells and Immune-Related Diseases.

Authors: Yang, Yaxu Han, Xue Sun, Lijun et al.

Source: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p10004. 13p.